RedHill Biopharma Ltd - Strategic SWOT Analysis Review

July 2020 | 40 pages | ID: RC84583CAD23EN
GlobalData

Abstracts

RedHill Biopharma Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

RedHill Biopharma Ltd (RedHill) is a biopharmaceutical company that develops and commercializes therapeutics in the areas of gastroenterology (GI) and cancer. The company’s commercial product portfolio consists of Donnatal for IBS and acute enterocolitis; Mytesi; Esomeprazole Strontium Delayed-Release Capsules 49.3 mg for GERD and other GI conditions; and EnteraGam, a medical food intended for the dietary management. It sells these specialty GI products in select US territories. RedHill is investigating pipeline candidates for the treatment of GI disorders and cancer that include helicobacter pylori infection, Crohn’s disease, multiple sclerosis and pancreatic cancer among others. RedHill is headquartered in Tel Aviv, Israel.

RedHill Biopharma Ltd Key Recent Developments

Jul 01,2020: RedHill Biopharma to present at the Sachs Novel Coronavirus Investment Forum
May 27,2020: RedHill Biopharma provides Q1/2020 financial results and recent highlights including initial Movantik revenues
Apr 21,2020: RedHill Biopharma partners with NIAID for potential Covid-19 drug
Mar 25,2020: RedHill Biopharma provides business update
Mar 04,2020: RedHill Biopharma provides full-year 2019 financial results and operational highlights

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

RedHill Biopharma Ltd - Key Facts
RedHill Biopharma Ltd - Key Employees
RedHill Biopharma Ltd - Key Employee Biographies
RedHill Biopharma Ltd - Key Operational Employees
RedHill Biopharma Ltd - Major Products and Services
RedHill Biopharma Ltd - History
RedHill Biopharma Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
RedHill Biopharma Ltd - Business Description
RedHill Biopharma Ltd - Corporate Strategy
RedHill Biopharma Ltd - SWOT Analysis
SWOT Analysis - Overview
RedHill Biopharma Ltd - Strengths
RedHill Biopharma Ltd - Weaknesses
RedHill Biopharma Ltd - Opportunities
RedHill Biopharma Ltd - Threats
RedHill Biopharma Ltd - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
RedHill Biopharma Ltd, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Jul 01, 2020: RedHill Biopharma to present at the Sachs Novel Coronavirus Investment Forum
May 27, 2020: RedHill Biopharma provides Q1/2020 financial results and recent highlights including initial Movantik revenues
Apr 21, 2020: RedHill Biopharma partners with NIAID for potential Covid-19 drug
Mar 25, 2020: RedHill Biopharma provides business update
Mar 04, 2020: RedHill Biopharma provides full-year 2019 financial results and operational highlights
Feb 25, 2020: AstraZeneca licences Movantik to RedHill Biopharma
Feb 25, 2020: RedHill Biopharma enters $115 Million non-dilutive financing agreement with HealthCare Royalty Partners
Jan 02, 2020: RedHill Biopharma regains rights to its proprietary bowel preparation RHB-106
Nov 19, 2019: RedHill Biopharma reports third quarter 2019 financial results and operational highlights
Nov 15, 2019: Dual-listed RedHill Biopharma to voluntarily delist from Tel-Aviv stock exchange

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

RedHill Biopharma Ltd, Key Facts
RedHill Biopharma Ltd, Key Employees
RedHill Biopharma Ltd, Key Employee Biographies
RedHill Biopharma Ltd, Key Operational Employees
RedHill Biopharma Ltd, Major Products and Services
RedHill Biopharma Ltd, History
RedHill Biopharma Ltd, Subsidiaries
RedHill Biopharma Ltd, Key Competitors
RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
RedHill Biopharma Ltd, Recent Deals Summary

List Of Figures

LIST OF FIGURES

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

COMPANIES MENTIONED

Unipharm Ltd
Therapix Biosciences Ltd
Dexcel PT Israel Ltd
Adare Pharmaceuticals Inc
Nutrinia Ltd